| Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial RH Gray, G Kigozi, D Serwadda, F Makumbi, S Watya, F Nalugoda, ... The lancet 369 (9562), 657-666, 2007 | 2955 | 2007 |
| Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda MJ Wawer, RH Gray, NK Sewankambo, D Serwadda, X Li, ... The Journal of infectious diseases 191 (9), 1403-1409, 2005 | 1652 | 2005 |
| Variation in false-negative rate of reverse transcriptase polymerase chain reaction–based SARS-CoV-2 tests by time since exposure LM Kucirka, SA Lauer, O Laeyendecker, D Boon, J Lessler Annals of internal medicine 173 (4), 262-267, 2020 | 1515 | 2020 |
| The natural history of hepatitis C virus infection: host, viral, and environmental factors DL Thomas, J Astemborski, RM Rai, FA Anania, M Schaeffer, N Galai, ... Jama 284 (4), 450-456, 2000 | 1420 | 2000 |
| Male circumcision for the prevention of HSV-2 and HPV infections and syphilis AAR Tobian, D Serwadda, TC Quinn, G Kigozi, PE Gravitt, ... New England Journal of Medicine 360 (13), 1298-1309, 2009 | 680 | 2009 |
| Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity E Shrock, E Fujimura, T Kula, RT Timms, IH Lee, Y Leng, ML Robinson, ... Science 370 (6520), eabd4250, 2020 | 472 | 2020 |
| Circumcision in HIV-infected men and its effect on HIV transmission to female partners in Rakai, Uganda: a randomised controlled trial MJ Wawer, F Makumbi, G Kigozi, D Serwadda, S Watya, F Nalugoda, ... The Lancet 374 (9685), 229-237, 2009 | 397 | 2009 |
| Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population SL Klein, A Pekosz, HS Park, RL Ursin, JR Shapiro, SE Benner, ... The Journal of clinical investigation 130 (11), 6141-6150, 2020 | 396 | 2020 |
| Effect of human immunodeficiency virus Type 1 (HIV-1) subtype on disease progression in persons from Rakai, Uganda, with incident HIV-1 infection N Kiwanuka, O Laeyendecker, M Robb, G Kigozi, M Arroyo, F McCutchan, ... The Journal of infectious diseases 197 (5), 707-13, 2008 | 355 | 2008 |
| Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda JH Oyugi, J Byakika-Tusiime, K Ragland, O Laeyendecker, R Mugerwa, ... Aids 21 (8), 965-971, 2007 | 338 | 2007 |
| Acute hepatitis C virus structural gene sequences as predictors of persistent viremia: hypervariable region 1 as a decoy SC Ray, YM Wang, O Laeyendecker, JR Ticehurst, SA Villano, ... Journal of virology 73 (4), 2938-2946, 1999 | 254 | 1999 |
| The effect of a conditional cash transfer on HIV incidence in young women in rural South Africa (HPTN 068): a phase 3, randomised controlled trial A Pettifor, C MacPhail, JP Hughes, A Selin, J Wang, FX Gómez-Olivé, ... The Lancet Global Health 4 (12), e978-e988, 2016 | 219 | 2016 |
| Male circumcision decreases acquisition and increases clearance of high-risk human papillomavirus in HIV-negative men: a randomized trial in Rakai, Uganda RH Gray, D Serwadda, X Kong, F Makumbi, G Kigozi, PE Gravitt, S Watya, ... The Journal of infectious diseases 201 (10), 1455-1462, 2010 | 217 | 2010 |
| COVID-19 serology at population scale: SARS-CoV-2-specific antibody responses in saliva N Pisanic, PR Randad, K Kruczynski, YC Manabe, DL Thomas, A Pekosz, ... Journal of clinical microbiology 59 (1), e02204-20, 2020 | 202 | 2020 |
| Effect of community-based voluntary counselling and testing on HIV incidence and social and behavioural outcomes (NIMH Project Accept; HPTN 043): a cluster-randomised trial TJ Coates, M Kulich, DD Celentano, CE Zelaya, S Chariyalertsak, ... The lancet global health 2 (5), e267-e277, 2014 | 170 | 2014 |
| SARS-CoV-2–specific CD8+ T cell responses in convalescent COVID-19 individuals H Kared, AD Redd, EM Bloch, TS Bonny, H Sumatoh, F Kairi, D Carbajo, ... The Journal of clinical investigation 131 (5), 2021 | 166 | 2021 |
| Comparative performance of five commercially available serologic assays to detect antibodies to SARS-CoV-2 and identify individuals with high neutralizing titers EU Patel, EM Bloch, W Clarke, YH Hsieh, D Boon, Y Eby, RE Fernandez, ... Journal of Clinical Microbiology 59 (2), e02257-20, 2021 | 164 | 2021 |
| HIV subtype D is associated with dementia, compared with subtype A, in immunosuppressed individuals at risk of cognitive impairment in Kampala, Uganda N Sacktor, N Nakasujja, RL Skolasky, M Rezapour, K Robertson, S Musisi, ... Clinical Infectious Diseases 49 (5), 780-786, 2009 | 159 | 2009 |
| Microbial translocation, the innate cytokine response, and HIV-1 disease progression in Africa AD Redd, D Dabitao, JH Bream, B Charvat, O Laeyendecker, N Kiwanuka, ... Proceedings of the National Academy of Sciences 106 (16), 6718-6723, 2009 | 155 | 2009 |
| Selection of HIV variants with signature genotypic characteristics during heterosexual transmission M Sagar, O Laeyendecker, S Lee, J Gamiel, MJ Wawer, RH Gray, ... The Journal of infectious diseases 199 (4), 580-589, 2009 | 151 | 2009 |
Thomas C Quinn, MD, MScNIAID, NIH, and JHUAdresse e-mail validée de jhmi.edu
